Scientists at A*STAR's Genome Institute of Singapore (GIS) have developed a new technique that simplifies the task of identifying the precise DNA mutations that cause disease, which lays the groundwork for the development ...
Apr 6, 2015
0
94
A technique to grow cells very similar to smooth muscle cells found in brain arteries, will make it easier to study the contribution of blood vessel disease to neurodegenerative conditions, a new study shows.
Dec 17, 2014
0
0
An international study led by Dr. Li Qi-Jing from the Agency for Science, Technology and Research (A*STAR) has revealed a mechanism by which melanoma, the most aggressive form of skin cancer, evades the immune system.
May 9, 2024
0
8
A recent discovery by scientists at A*STAR's Singapore Institute for Clinical Sciences (SICS), in close collaboration with researchers at the Singapore Immunology Network (SIgN), provides hope for a new personalised treatment ...
Sep 20, 2013
0
0
Researchers from A*STAR's Institute of Molecular and Cell Biology (IMCB) and National Cancer Centre Singapore (NCCS) have discovered how the loss of a gene, PBRM1, can lead to the development of kidney cancer. The work is ...
Jul 28, 2023
0
54
Exposure to Hepatitis B virus (HBV) in utero can help 'mature' a human neonatal immune system and may improve the capacity of human neonatal immune cells to respond to secondary infections, an international research team ...
Nov 4, 2015
0
18
The artificial enhancement of the body's natural immune defenses is a potential weapon in the battle against diseases such as leukemia. A*STAR researchers are honing methods to boost the interactions between antibodies and ...
Mar 23, 2016
0
17
Babies born to mothers who develop diabetes during pregnancy – known as gestational diabetes (GDM) – are shown to have attentional deficiencies as early as 6–18 months of age, suggesting the need to reduce insulin resistance ...
Jul 12, 2017
0
2
Scientists from A*STAR's Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS), as well as the NUS Cancer Science Institute of Singapore (CSI Singapore), National Cancer Center Singapore (NCCS) ...
Jul 20, 2022
0
11
Tyrosine kinase inhibitors (TKIs) kill cancerous cells by inducing programmed cell death. They are of enormous therapeutic benefit to patients with chronic myeloid leukemia (CML) and certain types of lung cancer, but their ...
Aug 2, 2012
0
0
